Over 80% Indian youngsters use s…

New Delhi: More than eigh…

We will set rules, not you: US m…

Washington:  The American…

Learning outcomes to become enfo…

New Delhi:  Union HRD Min…

Congress demands RBI Governor's …

New Delhi:  The Congress …

Mobile screen-recorded short fil…

Kochi:  A 90-second-long …

Malaysia lifts curbs on hiring f…

Kaula Lumpur:  Citing cri…

Rising digital payments lead to …

New Delhi:  Digital payme…

Sheena Bora case: Mother, step-d…

Mumbai:  A Special CBI Co…

Short queues outside ATMs, but m…

The rush for cash in the …

Massive protest against Jallikat…

Chennai:  Hundreds of peo…

«
»
TwitterFacebookPinterestGoogle+

Anticoagulants Market Continued to be driven by Aging Population and Rising Prevalence of Coagulation Disorders: Ken Research

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Anticoagulants are class of drug used for prevention of blood clots. These substances are majorly available in leeches and blood-sucking insects. These drugs have found major application in treatment of thrombotic disorders and as supporting drug during dialysis. The drug is applied on test tubes, transfusion bags, and renal dialysis equipment for proper functioning. Though the drug class results in various side effects; anticoagulants play an important role in treatment of atrial fibrillation, coronary artery disease, deep vein thrombosis, ischemic stroke, myocardial infraction and pulmonary embolism.
Global anticoagulants market is broadly divided by type into six segments including Heparin, Warfarin, Noval Oral Anticoagulants, Vitamin K Antogonists, Direct Thrombosis Inhibitors, and others. The market is also segmented on the basis of route of administration into oral and injections. Various global pharmaceutical giants including Pfizer, Sanofi, GSK, and Baxter provide anticoagulants in their portfolio for prevention of blood clots.
Aging population and rising prevalence of coagulation disorders are the major factors which are expected to drive the anticoagulants market during future. However, unawareness about the disease especially in emerging and undeveloped economies of Asia, Latin America and Africa results in large number of undiagnosed cases of coagulation disorders, hence restraining the market.

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA Image

*

Sections

Shows

Other News

About Us

Follow Us